Moonlake Immunotherapeutics Ag
Clinical trials sponsored by Moonlake Immunotherapeutics Ag, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug trial aims to help teens with painful skin condition Results expected Sep 2026 (estimated)
- New hope for psoriatic arthritis sufferers: experimental drug sonelokimab enters final testing phase Results expected Jan 2027 (estimated)
- New drug sonelokimab aims to ease psoriatic arthritis pain Results expected Feb 2027 (estimated)